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Neurolipids are a class of bioactive lipids that are produced locally through specific
biosynthetic pathways in response to extracellular stimuli. Neurolipids are important
endogenous regulators of neural cell proliferation, differentiation, oxidative stress,
inflammation and apoptosis. Endocannabinoids (eCBs) and lysophosphatidic acid
(LPA) are examples of this type of molecule and are involved in neuroprotection.
The present study analyzes a possible relationship of the main receptor subtypes
for both neurolipid systems that are present in the central nervous system, the CB1
and LPA1 receptors, by using brain slices from CB1 KO mice and LPA1-null mice.
Receptor-mediated G protein activation and glycerophospholipid regulation of potential
precursors of their endogenous neurotransmitters were measured by two different
in vitro imaging techniques, functional autoradiography and imaging mass spectrometry
(IMS), respectively. Possible crosstalk between CB1 and LPA1 receptors was identified
in specific areas of the brain, such as the amygdala, where LPA1 receptor activity is
upregulated in CB1 KO mice. More evidence of an interaction between both systems
was that the CB1-mediated activity was clearly increased in the prefrontal cortex
and cerebellum of LPA1-null mice. The eCB system was specifically over-activated in
regions where LPA1 has an important signaling role during embryonic development.
The modifications on phospholipids (PLs) observed in these genetically modified mice
by using the IMS technique indicated the regulation of some of the PL precursors of both
LPA and eCBs in specific brain areas. For example, phosphatidylcholine (PC) (36:1) was
detected as a potential LPA precursor, and phosphatidylethanolamine (PE) (40:6) and PE
(p18:0/22:6) as potential eCB precursors. The absence of the main cerebral receptors
for LPA or eCB systems is able to induce modulation on the other at the levels of both
signaling and synthesis of endogenous neurotransmitters, indicating adaptive responses
between both systems during prenatal and/or postnatal development.
Keywords: neurolipids, lysophosphatidic acid, cannabinoids, GPCR, autoradiography, imaging mass
spectrometry, brain
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INTRODUCTION
During past decades, lipid molecules present in the CNS were
considered components of cell membranes and organelles,
intermediary metabolites, or constituents of the energy
reservoirs. Currently, it is known that neurolipids are
bioactive molecules that can act as neurotransmitters with
neuromodulatory properties. Studies analyzing lipid molecules
related to signaling systems are clarifying the complex integration
of different lipid-metabolic pathways with other physiological
functions mediated by lipids. The involvement of lipids in
physiological and pathological processes can now also be
analyzed by the development of new and potent analytical tools
and instruments that enable rapid, high-throughput lipidomic
analyses of rodent and human brain tissue sections at anatomical
resolution, such as IMS (Gonzalez de San Roman et al., 2017;
Martinez-Gardeazabal et al., 2017).
Lipid mediators, synthesized from glycerophospholipids, are a
class of bioactive lipids that are produced locally through specific
biosynthetic pathways in response to extracellular stimuli.
These lipid molecules, which hereafter we will call neurolipids,
mediate neurotransmission as important endogenous regulators
of multiple cerebral processes related to neuroprotective actions,
such as neural cell proliferation, differentiation, response
to oxidative stress, inflammation and apoptosis. Neurolipids
are transported to extracellular compartments (by non-well-
defined mechanisms), usually bind to specific GPCRs to trigger
intracellular signaling and responses in target cells, and then
are sequestered rapidly through enzymatic or non-enzymatic
processes (Murakami, 2011). Representative members of this
class of neurolipids are eCBs and the LP, LPA.
The first CB receptor cDNA was cloned in 1990 as the
first GPCR for lipid mediators (Matsuda et al., 1990). Two CB
subtypes have been cloned: CB1, the most abundant CB receptor
subtype in the CNS, and CB2, which is more restricted to glial
cells. However, the CB2 receptor appears to be expressed by
some neurons, particularly under certain pathological conditions
(Van Sickle et al., 2005; Viscomi et al., 2009; Garcia-Gutierrez
and Manzanares, 2011; Navarrete et al., 2012). Moreover, there
is evidence for other possible G protein-coupled CBs in the
brain (Jarai et al., 1999; Di Marzo et al., 2000; Breivogel et al.,
2001). Concerning the other above-mentioned LPs, the first
high-affinity cognate cell surface receptor for LPA that was
identified as the most abundant in the CNS was LPA1, but two
additional receptors have been identified (LPA2 and LPA3). More
recently, another three LPA receptors were identified, which were
somewhat divergent receptors (LPA4, LPA5, LPA6) (reviewed
in Choi et al., 2010; Yung et al., 2014). These two families
of GPCRs, the CB and the LPA GPCRs, are phylogenetically
Abbreviations: 2-AG, 2-araquidonoil glycerol; AEA, anandamide; cb WM,
cerebellum white matter; CB, cannabinoid receptor; cc, corpus callosum; Cx layer
VI, frontal cortex layer VI; eCB, endocannabinoid; GlcCer, glucosylceramide;
GPCR, G protein-coupled receptor; ic, internal capsule; LP, lysophospholipid; LPA,
lysophosphatidic acid; MALDI-IMS, matrix-assisted laser desorption/ionization
imaging mass spectrometry; PA, phosphatidic acid; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; ROI, region of interest; TIC, total ion current; VZ,
ventricular zone.
related. CBs share 18–20% identity of the amino acid sequence
with LPA receptors, in particular with LPA1, LPA2, and LPA3
(Chun et al., 1999).
Both LPA and eCBs are synthesized mainly by the cleavage
of phospholipids (PLs), probably at the cell membrane. The
distribution pattern of CB1 and CB2 receptors in the developing
and adult brain is highly correlated with the expression of the
DAGLα/β enzymes, responsible for 2-AG synthesis, suggesting
that PL precursors would also be closely localized (Bisogno et al.,
2003; Yoshida et al., 2006; Oudin et al., 2011). However, little is
known about the specific lipid species that constitute the eCB
precursors and particularly, about their specific localization in
the brain (Lu and Mackie, 2016). Therefore, one of the aims of
the present study is to identify these potential precursors through
MALDI-IMS assays. This technique has enriched lipidomic
studies due to the new dimensions added by IMS, i.e., the
anatomical mapping of the molecules in tissue sections, a key
piece of information to understand the physiological roles played
by lipids present in the tissue (Caprioli et al., 1997; Jackson et al.,
2005; Skraskova et al., 2015; Mohammadi et al., 2016).
Supporting the relationship between the eCB and
LPA systems, it is relevant that the endogenous ligands
for these systems are closely related, e.g., 2-AG can be
metabolized to 2-arachidonoyl-LPA through the action of a
monoacylglycerol kinase (Kanoh et al., 1986; Shim et al., 1989).
The opposite direction of this phosphorylation reaction, i.e.,
dephosphorylation, also seems to be possible (Hiroyama and
Takenawa, 1998; Nakane et al., 2002). Thus, it appears that
2-arachidonoyl-LPA and 2-AG could be mutually interconverted
within a cell, and the direction of the reaction may even differ
among the subcellular compartments within the cells and could
be modified depending on the availability of substrates, such as
ATP (Zhao and Abood, 2013). However, 2-arachidonoyl LPA
would not directly interact with the cannabinoid CB1 receptor,
and 2-AG, in turn, would not display affinity for the LPA1
receptor (Nakane et al., 2002). Moreover, structural analyses of
the crystal structure of antagonist-bound LPA1 receptor predict
a functional crosstalk with CB1 receptors (Chrencik et al., 2015).
During the last decade, the roles of the eCB and LPA
systems in the regulation of neuronal progenitor proliferation
and differentiation have been described, involving both systems
in neurogenesis at the subventricular zone (Birgbauer and Chun,
2006; Galve-Roperh et al., 2006). However, LPA, through binding
to the LPA1 receptor, acts only during the prenatal development
of the brain (Hecht et al., 1996). In the meantime, eCBs, through
binding to CB1 and CB2 receptors, regulate the migration
of subventricular zone-derived neuroblasts in the postnatal
brain (Oudin et al., 2011). Nevertheless, the eCB system may
also control embryonic neuronal development and maturation
(Diaz-Alonso et al., 2012).
In addition, both systems display relevant roles in the limbic
brain areas and pathways that control emotional processes, such
as the amygdala connections, where both systems are involved
in the extinction of fear-conditioned responses (Marsicano et al.,
2002; Tan et al., 2010; Pedraza et al., 2014). Furthermore,
both systems seem to be involved in the control of cognitive
processes linked to the hippocampus, such as spatial memory.
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maLPA1-null mice showed, through the LPA1 receptor-signaling
pathway, long-term spatial memory impairment, but not short-
term memory impairment (Castilla-Ortega et al., 2010).
On the other hand, direct hippocampal CB1 activation
by high doses of exogenous or endogenous cannabinoid
compounds induce characteristic long-term memory impairment
(Puighermanal et al., 2009). In the same way, the genetic deletion
of CB1 receptor induces neuronal loss in CA1 and CA3 areas of
the hippocampus, which triggers a decline in cognitive functions
(Bilkei-Gorzo et al., 2005).
In summary, both neurolipid systems are implicated in
cortical development in the prenatal brain, in the extinction
of fear-conditioned behavior in the amygdala, and in the
modulation of long-term memory in the hippocampus,
suggesting a convergence in the control of similar physiological
functions in the CNS. In the present study we analyze the
adaptive changes that are probably produced during mouse
prenatal and postnatal development in the eCB and LPA
neurolipid systems using both maLPA1-null and CB1 KO mice,
to analyze the interactions and crosstalk between the CB1
and LPA1 mediated-activities and to identify the anatomical
localization of the possible precursors of the endogenous ligands
for both signaling systems. Technically, the study combines
functional [35S]GTPγS autoradiography with MALDI-IMS to
analyze consecutive brain slices.
MATERIALS AND METHODS
Chemicals
[35S]GTPγS (initial specific activity 1250 Ci/mmol) was
purchased from Perkin Elmer (Boston, MA, United States).
WIN55212-2 was purchased from Tocris (Bristol,
United Kingdom). Oleoyl-L-α-lysophosphatidic acid sodium
salt (LPA), 2-mercaptobenzothiazole (MBT), DL-dithiothreitol
(DTT), guanosine-5′-diphosphate (GDP), guanosine-5′-o-3-
triphosphate and β-radiation sensitive Kodak Biomax MR
films were acquired from Sigma-Aldrich (St. Louis, MO,
United States). The [14C]-microscales used as standards
in the autoradiographic experiments were purchased from
Amersham Biosciences (Buckinghamshire, United Kingdom)
and American Radiolabeled Chemicals (ARC, St. Louis, MO,
United States). Finally, for the preparation of the different
buffers, the treatment of slides, re-crystallization of the matrix
and film development, several additional compounds supplied
from different laboratories were used. All the compounds were
of the highest commercially available quality for the necessity of
the neurochemical studies.
Animals and Tissue Preparation
maLPA1-null homozygous (n = 8) and wild-type 3-month-old
males (n = 8) (on a mixed background C57Bl/6 × 129SW)
were obtained from Hospital Carlos Haya, Málaga, Spain, as a
result of a collaboration with Dr. Estivill-Torrús’s research group.
The maLPA1-null (from Málaga variant of LPA1-null) mouse
colony arose spontaneously from the initially reported LPA1-
null mouse line (Contos et al., 2000) while crossing heterozygous
foundational parents within their original mixed background
since phenotypic variations have been described in almost
complete perinatal viability and show a reduced VZ, altered
neuronal markers, and increased cortical cell death that results in
a loss of cortical layer cellularity in adults (Estivill-Torrus et al.,
2008; Matas-Rico et al., 2008).
CB1-knockout mice are a strain maintained at the University
of the Basque Country and were provided by C. Ledent of the
University of Brussels (Belgium). For this study, 9 week-old male
CB1-knockout (n = 5) and wild-type mice (n = 5) were used. The
generation of mice lacking CB1 CBs was described previously
(Ledent et al., 1999). To homogenize the genetic background
of the mice, the first generation of heterozygous mice was bred
for 30 generations on a CD1 background, with selection for the
mutant CB1 gene at each generation. Mice were housed in a
temperature (22◦C) and humidity-controlled (65%) room with
a 12:12-h light/dark cycle (light between 08:00 and 20:00 h),
with food and water ad libitum. All procedures were performed
in accordance with European animal research laws (European
Communities Council Directives 86/609/EEC, 98/81/CEE and
2003/65/CE; Commission Recommendation 2007/526/EC) and
the Spanish National Guidelines for Animal Experimentation
and the Use of Genetically Modified Organisms (Real Decreto
1205/2005 and 178/2004; Ley 32/2007 and 9/2003). All the
experimental protocols were approved by the Local Ethics
Committee for Animal Research at the University of the Basque
Country (CEIAB/21/2010/Rodriguez Puertas).
Mouse brains were quickly removed under anesthesia. Then,
tissues were frozen on dry ice and kept at−80◦C. The brains were
cut on a Microm HM550 cryostat (Thermo, Germany) to obtain
20 µm sections that were mounted onto gelatin-coated slides, and
these were stored at−20◦C until use.
[35S]GTPγS Binding Assay
The tissue sections were air-dried for 15 min then washed in
HEPES-based buffer (50 mM HEPES, 100 mM NaCl, 3 mM
MgCl2, and 0.2 mM EGTA, pH 7.4) for 30 min at 30◦C in
a water bath. The preincubation was repeated in new buffer.
In a second step, the slides were incubated for 2 h at 30◦C
supplemented with 2 mM GDP, 1 mM DTT, adenosine deaminase
(3 µ/l) and 0.04 nM [35S]GTPγS. The agonist-stimulated binding
was measured under the same conditions in the presence of the
specific GPCR agonists oleoyl-L-α-lysophosphatidic acid sodium
salt; LPA (10−5 M) and WIN55212-2 (10−5 M). Non-specific
binding was determined in the presence of 10 µM non-labeled
GTPγS. Sections were washed twice in an ice-cold (4◦C) HEPES
buffer (50 mM, pH 7.4), dipped in distilled water, and air-dried.
Sections were exposed to autoradiography film (Kodak Biomax
MR) together with 14C standards for 48 h at 4◦C in hermetically
closed cassettes.
Quantitative Image Analysis of
Autoradiograms
Films were scanned and quantified by transforming the optical
densities into nCi/g of tissue equivalent (nCi/g t.e.) using
ImageJ software (NIH-IMAGE, Bethesda, MA, United States)
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(developed at the U.S. National Institutes of Health and freely
available on https://imagej.nih.gov/ij/). The [14C] radioactive
standards that were co-exposed with the tissue slides were used
to calibrate the optical densities with the level of radioactivity
labeled to the sections. Experimental data were analyzed by using
the computer programs GraphPad Prism (v. 5.0, GraphPad) and
Microsoft Excel. Data are expressed as the mean values ± SEM.
The basal binding was calculated as nCi/g tissue equivalent,
using the values provided in the 14C microscales. The agonist
stimulation of [35S]GTPγS binding is expressed by the percentage
of stimulation over the basal (%) in the presence of the
different agonists, calculated as: (([35S]GTPγS agonist-stimulated
binding) × 100/([35S]GTPγS basal binding)) − 100. The regions
of interest (ROI) were defined from the scanned film in the
case of the GTPγS autoradiography and directly from the image
obtained from MALDI-IMS, using counter stained consecutive
sections and a mouse brain atlas, without knowing the genotype
of the mice and without taking into account the intensities of the
rest of the animals. Differences between regions for each mouse
genotype (wild type vs. transgenic) were analyzed by the unpaired
two-tailed Student’s t test.
Sample Preparation for MALDI-IMS
The original lipid composition and anatomical characteristics
of the tissue must be well-preserved throughout the sample-
preparation process (Schwartz et al., 2003). The fresh-frozen
brains of the mice were cut on a Microm HM550 cryostat
(Thermo, Germany) to obtain 20 µm sections and stored at
−20◦C until the moment of use.
Once the initial tissue preparation steps were completed, the
matrix was deposited on the tissue surface prior to analysis by
a sublimation process using the protocol described by Gonzalez
de San Roman et al. (2017). For tissue sections mounted on
glass slides, sublimation was performed using 300 mg of MBT,
which was used as a chemical matrix, to control the deposition
time and temperature (30 min, 140◦C). Therefore, it was possible
to control the thickness of the matrix layer and optimize
the S/N ratio of the mass spectra, avoiding lipid migration
on the tissue slice thanks to the lack of solvents using this
sublimation procedure.
Mass Spectrometer
A MALDI LTQ-XL-Orbitrap (Thermo Fisher, San Jose, CA)
equipped with a nitrogen laser (λ = 337 nm, rep. rate = 60 Hz,
spot size = 80 × 120 µm) was used for mass analysis. Thermo’s
ImageQuest and Xcaliber software were used for MALDI-IMS
data acquisition. The images were acquired in both negative and
positive ion modes. The positive ion range was 500–1000 Da, with
10 laser shots per pixel at a laser fluence of 15 µJ. The negative
ion range was 400–1100 Da, with 10 laser shots per pixel at a
laser fluence of 15 µJ. The target plate stepping distance was
set to 150 µm for both the x- and y-axes by the MSI image
acquisition software. The mass resolution was approximately
100,000 laser shots in both positive and negative ion modes. The
data were normalized using the TIC values to avoid potential
displacement in the masses along the tissue that may be induced
by experimental factors, including irregularities of the surface.
Image and Spectral Analysis for
MALDI-IMS
The MALDI-IMS technique was applied to localize and semi-
quantitatively analyze the different lipid species present in WT
and maLPA1-null mice in positive and negative ion detection
modes. We employed optimized experimental conditions for
lipid detection previously set up by our research group and
others, including selection of the MBT chemical matrix and
deposition mode by sublimation procedures (Astigarraga et al.,
2008; Yang and Caprioli, 2011). First, IMS of sagittal mouse brain
sections was performed using the positive ion detection mode,
and approximately 300 mass peaks were detected in the mass
range from 500 to 900 m/z. Then, the same slices of tissue were
analyzed in negative ion detection mode using a mass range
from 400 to 1100 m/z. A complete mass spectrum was obtained
from each pixel along all the surface of each brain tissue slice,
obtaining the slice images as a composition of the intensity color
of each peak (molecule or m/z) at each pixel. Specifically, an ion
of interest can be extracted from the spectra, and an image of that
particular ion distribution in the tissue can be visualized. Once we
had analyzed at least five sagittal brain slices samples from five
different animals of WT and another five samples of maLPA1-
null mice, we selected different ROIs, such as hippocampus,
cortex, cerebellum, cc, and striatum. The spectrum normalization
was calculated using the TIC for each mass to exclude a number
of noise spectra. Next, we compared WT and maLPA1-null using
Origin R©8 software.
In summary, the MALDI images were generated using
ImageQuest software (Thermo Scientific). Each of the m/z
values was plotted for signal intensity per pixel (mass spectrum)
across a given area (tissue section). The m/z range of interest
was normalized using the ratio of the TIC for each mass
spectrum. The intensity reached by each mass spectrum (intensity
of each peak, m/z value or molecule) was further calculated
as a ratio of the peak with the highest intensity, and the
average spectrum was calculated with OriginPro 8 software
(Northampton, MA, United States). The most intense peak
was considered 100%. Then, the two-tailed unpaired t test was
performed for the comparison of two groups. The results were
considered significant if p ≤ 0.05.
Peak Assignment
Analysis of the lipid composition at CNS tissue samples from
mice included in the present study was complex. A large number
of different possible lipid species were detected, and some of them
shared similar masses and were not detected and/or assigned to
a specific lipid molecule by previous studies. Nevertheless, the
assignment of lipid species was facilitated by the use of the Lipid
MAPS database1 and different previous reports (Berry et al., 2011;
Martinez-Gardeazabal et al., 2017), using a 5 ppm mass accuracy
as the tolerance window for the assignment. The numbers (x:y)
following the glycerolipid species denote the total length and the
number of double bonds of the acyl chains, respectively, while the
GlcCer species numbers correspond to the length and number
1http://www.lipidmaps.org/
Frontiers in Molecular Neuroscience | www.frontiersin.org 4 September 2019 | Volume 12 | Article 223
fnmol-12-00223 September 17, 2019 Time: 17:21 # 5
González de San Román et al. Relationship Between CB1 and LPA1 Receptors
of double bonds of the acyl chain added to those of the attached
sphing-4-enine (d18:1) or sphinganine (d18:0) base.
RESULTS
[35S]GTPγS Binding Assay of
maLPA1-Null Mouse Brain Sections
The [35S]GTPγS binding stimulated by WIN55212-2 was
measured in brain slices of maLPA1-null and WT mice to localize
and quantify the activity of CB1 CBs. The aim was to observe, in
adult mice was the possible modulation of cannabinoid signaling
that was induced by the lack of the LPA receptor subtype, LPA1,
during the animal’s previous development. The basal activity (in
the absence of agonist) of the Gi/o-coupled GPCR in maLPA1-
null mice was already shown in Gonzalez de San Roman et al.
(2015). The Gi/o-coupled CB1 receptor activity induced by the
CB1 agonist WIN55212-2 was increased at the prefrontal cortex
layers I–III (WT 212 ± 19% vs. maLPA1-null 369 ± 49%,
p ≤ 0.05) and in layer VI (WT 284 ± 14% vs. maLPA1-null
396 ± 22%, p ≤ 0.05). The increase in the CB1 activity was also
significant in the cerebellum gray matter (cb GM) of maLPA1-
null mice compared to WT (WT 23 ± 15% vs. maLPA1-null
107± 13%, p≤ 0.05) and cb WM (WT 678± 149% vs. maLPA1-
null 1377 ± 207%, p ≤ 0.05). The globus pallidus, a nucleus
with a high density of CB1 receptors in mice, also showed an
increase in the activity of these receptors in maLPA1-null mice
(WT 1705± 151% vs. maLPA1-null 2037± 82%), but this change
was not statistically significant (Table 1 and Figure 1). The
[35S]GTPγS binding stimulated by oleoyl-L-α-lysophosphatidic
acid sodium salt (LPA) showed no stimulations in any brain area
of the maLPA1-null mice, demonstrating the specificity of the
experimental binding procedure and the right phenotype of the
animals (Gonzalez de San Roman et al., 2015).
[35S]GTPγS Binding Assay in CB1 KO
Mouse Brain Sections
We compared the [35S]GTPγS binding stimulated by LPA
in CB1 KO and WT mice to observe the consequences of
the developmental absence of the main eCB receptor on the
signaling through cerebral GPCRs for the LPA1 receptors. There
were statistically significant changes that were restricted to the
amygdala and showed increased [35S]GTPγS binding induced
by LPA (WT −20 ± 4.3% vs. CB1 KO 32 ± 6.3%, p ≤ 0.05).
The LPA1 receptor activity of CB1 KO mice was comparable
to WT mice in all the other brain areas that were analyzed
(Table 2 and Figure 2). The [35S]GTPγS binding stimulated by
WIN55212-2 showed no stimulation in any brain area of the
CB1 KO mice, demonstrating the specificity of the experimental
binding procedure and the right phenotype of the animals
(data not shown).
MALDI-IMS in maLPA1-Null Mouse Brain
Sections
Some lipid species showed changes in positive ion detection
mode in maLPA1-null mice compared to WT mice. Three lipid
species, GlcCer (d18:1/14:0) + K+ in cortex (WT 14.5 ± 0.8%
vs. maLPA1-null 9.3 ± 1.5%, p < 0.05) and striatum (WT
22.0 ± 1.3% vs. maLPA1-null 15.2 ± 2.3%, p ≤ 0.05), PA
(16:0/18:1)+ K+ in hippocampus (WT 46.5± 2.0% vs. maLPA1-
null 37.2 ± 3.4%, not significant) and cortex (WT 47.5 ± 2.0%
vs. maLPA1-null 37.3 ± 3.5%, p ≤ 0.05), and PC(32:0)+ in
hippocampus (WT 27.3 ± 3.6% vs. maLPA1-null 17.9 ± 0.5%,
p ≤ 0.05), were present at lower levels in maLPA1-null mice.
By contrast, the intensity of the peaks for PC(36:1) + K+ in
hippocampus (WT 16.3 ± 0.8% vs. maLPA1-null 20.4 ± 0.5%,
p < 0.05) and cortex (WT 15.8 ± 0.7% vs. maLPA1-null
19.6 ± 1.5%, p ≤ 0.05), PC(38:4) + K+ in hippocampus
(WT 8.4 ± 0.4% vs. maLPA1-null 11.3 ± 1.0%, p ≤ 0.05)
and cortex (WT 10.3 ± 0.7% vs. maLPA1-null 13.5 ± 1.1%,
p ≤ 0.05) and PC(38:6) + K+ in hippocampus (WT 12.0 ± 0.6%
vs. maLPA1-null 15.7 ± 0.9%, p ≤ 0.05) was higher in the
KO mice (Table 3 and Figure 3. See “p” values in table of
Supplementary Material).
MALDI-IMS in CB1 KO Mouse Brain
Sections
The results of the MALDI-IMS experiments using CNS slices
from WT and CB1 KO mice were also performed in positive
and negative ion detection modes. As has been described,
we used an optimized protocol for the lipid detection. The
analysis of IMS on sagittal mouse brain slices was performed
in positive ion detection mode in a mass range from 500 to
1000 m/z and in negative ion detection mode from 400 to
1100 m/z. We selected the ROI and followed the steps described
in the “Materials and Methods” section. The results indicated
TABLE 1 | [35S]GTPγS binding induced by WIN55212-2 (10 µM) in different areas
of WT and maLPA1-null mice, calculated as percentage over the basal value.
Stimulation by WIN55212-2 (%)
Brain region WT maLPA1-null p-value
Amygdala 362 ± 50 232 ± 22 0.06
Cerebellum
White matter 2.3 ± 15 107 ± 13∗ 0.001
Gray matter 679 ± 149 1377 ± 207∗ 0.04
Corpus callosum 108 ± 20 150 ± 11 0.18
Striatum 254 ± 18 255 ± 23 0.75
Frontal cortex
Layer I–III 212 ± 19 369 ± 49∗ 0.05
Layer IV 188 ± 33 236 ± 14 0.27
Layer V 223 ± 25 282 ± 12 0.07
Layer VI 284 ± 14 396 ± 22∗ 0.02
Hippocampus
Dorsal CA1 radiata 371 ± 51 341 ± 38 0.69
Ventral CA3 radiata 288 ± 23 266 ± 12 0.51
Internal capsule 53 ± 16 33 ± 14 0.28
Globus pallidus 1705 ± 151 2037 ± 82 0.21
Data are mean ± SEM values, in percentage of stimulation over the basal (%). The
p-values were calculated by the unpaired two-tailed Student’s t test. ∗p ≤ 0.05.
WT(n = 8) and maLPA1null (n = 8).
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FIGURE 1 | Representative autoradiograms of WT (A) and maLPA1-null mice (B) in sagittal sections that show [35S]GTPγS binding stimulated by WIN55212-2 (10-5
M). Note the increase in the binding in maLPA1-null mice at different cortical layers (Layer I–III and Layer VI) and at the cerebellar gray matter (cb GM) and white
matter (cb WM). Scale bar = 3 mm.
that some lipid species were modified in the brain of CB1
KO mice in both positive and negative ion detection modes.
Some lipid species were present at a higher intensity than in
WT mouse brain. These lipid species included PC(32:0)+ in
hippocampus (WT 37.6 ± 3.6% vs. CB1 KO 65.3 ± 3.1%,
p < 0.01) and cortex (WT 33.2 ± 3.7% vs. CB1 KO
54.7 ± 6.5%, p < 0.05) and PC(34:1)+ also in hippocampus
(WT 48.6 ± 5.0% vs. CB1 KO 67.7 ± 3.5%, p < 0.05)
and cortex (WT 51.2 ± 4.8% vs. CB1 KO 69.5 ± 4.5%,
p < 0.05). Both PC molecules were increased in the frontal
cortex, hippocampus and striatum but were not modified in
the cerebellum of the CB1 KO mice. In contrast, the relative
intensities of other lipid species were lower in CB1 KO mice
TABLE 2 | [35S]GTPγS binding induced by LPA (10 µM) in different areas of WT
and CB1 KO mouse brains, calculated as stimulation percentage over basal.
Stimulation by LPA (%)
Brain region WT CB1 KO p-value
Amygdala −20 ± 4.3 32 ± 6.3∗ 0.0008
Cerebellum
White matter 229 ± 56 124 ± 46 0.2
Gray matter 50 ± 6.5 51 ± 27 0.96
Corpus callosum 343 ± 72 325 ± 59 0.84
Striatum 21 ± 9.3 24 ± 5.5 0.8
Frontal cortex
Layer I–III 60 ± 19 46 ± 21 0.6
Layer IV 53 ± 14 57 ± 27 0.62
Layer V 50 ± 11 64 ± 26 0.64
Layer VI 48 ± 15 62 ± 28 0.57
Hippocampus
Dorsal CA1 radiata 42 ± 11 18 ± 23 0.38
Ventral CA3 radiata 1.4 ± 13 14 ± 5 0.44
Internal capsule 203 ± 41 210 ± 44 0.91
Globus pallidus 2.2 ± 11 62 ± 42 0.16
Data are mean ± SEM values, in percentage of stimulation over basal (%). SEM
values, in percentage of stimulation over basal (%). The p-values were calculated
by the unpaired two-tailed Student’s t test. ∗p ≤ 0.05. WT (n = 5) and CB1 KO
(n = 5).
than in WT mice in the hippocampus, frontal cortex and
cerebellum but not modified in the striatum. These lipid species
included PE(p18:0/22:6) in hippocampus (WT 3.4 ± 0.2% vs.
CB1 KO 1.1 ± 0.6%, p < 0.05) and cortex (WT 3.7 ± 0.1%
vs. CB1 KO 1.0 ± 0.6%, p < 0.05), PE(18:0/22:6)− in
hippocampus (WT 8.5 ± 0.3% vs. CB1 KO 4.4 ± 1.9%,
p < 0.01), and phosphatidylserine (PS) (18:0/22:6)− in cortex
(WT 73.3 ± 9.5% vs. CB1 KO 46.9 ± 4.7%, p < 0.01)
and striatum (WT 57.9 ± 4.8% vs. CB1 KO 40 ± 2.7%,
p < 0.05) (Table 4 and Figure 4. See “p” values in table of
Supplementary Material).
DISCUSSION
The present study shows specific anatomical alterations of a few
lipid species that are potential PL precursors of LPA or eCBs,
analyzing simultaneously in the same animals the regulation of
the signaling by their specific CB1 and LPA1 receptors in KO mice
for each of these receptors, which are the respective predominant
subtypes present in the CNS. The analyzed regions were selected
attending to previously described brain areas showing high
densities of LPA1 or CB1 receptors.
The analysis of the activity of CB1 receptors in maLPA1-null
mice allowed us to detect a regulation mechanism in both in
the frontal cortex and in the cerebellum. The absence of LPA1
in maLPA1-null mice results in a reduction of neural cells in
layers II/III, V, and VI, increased apoptosis, alterations in the
formation of the cerebral cortex and premature expression of
neuronal markers (Estivill-Torrus et al., 2008). The eCB system
is a critical component of frontal cortex physiology. The CB1
receptor is mainly expressed in layers II/III and V/VI (Lafourcade
et al., 2007), same areas where there is a depletion of neurons in
maLPA1-null mice. Therefore, the increased functional activity
of CB1 receptors suggests a compensatory effect of the eCB
system to balance the neuronal reduction. Furthermore, the
cerebellum is another brain area where we detected an increase
in CB1 receptor activity in maLPA1-null mice. Cannabinoids
modulate the proliferation of cerebellar neuronal precursors via
the CB1 receptor (Trazzi et al., 2010). Hence, the lack of the
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FIGURE 2 | Autoradiographic images of sagittal sections from WT (A) and CB1 KO mice (B) showing [35S]GTPγS binding stimulated by LPA (10-5 M). Note the
increase in the binding at the amygdala in CB1 KO mice. Scale bar = 3 mm.
TABLE 3 | MALDI-IMS intensities (expressed as % of the most abundant peak) of molecular species of PC and PA that were found modified in positive ion detection
mode in sagittal brain sections from WT (n = 5) compared to the maLPA1-null (n = 5).
Cortex Hippocampus Striatum Corpus callosum Cerebellum
Assignment m/z WT LPA1-null WT LPA1-null WT LPA1-null WT LPA1-null WT LPA1-null
GlcCer(d18:1/14:0) + K+ 710.4899 14.5 ± 0.8 9.3 ± 1.5∗∗ 22.6 ± 1.0 19.1 ± 2.4 22.0 ± 1.3 15.2 ± 2.3∗ 14 ± 0.9 11.1 ± 1.7 21.3 ± 2.3 21.1 ± 3.5
PA(16:0/18:1) + K+ 713.4535 47.6 ± 2.0 37.3 ± 3.5∗ 46.5 ± 2.0 37.2 ± 3.4∗ 45.1 ± 2.2 35.3 ± 3.3∗ 34.6 ± 2.9 28.9 ± 2.9 34.5 ± 1.1 32.2 ± 4.3
PC(32:0)+ 734.5700 20.2 ± 3.2 25.3 ± 7.1 27.1 ± 3.6 17.9 ± 1.7∗ 28.1 ± 3.3 26.7 ± 6.1 19.5 ± 3.0 20.9 ± 4.3 21.4 ± 2.2 22.7 ± 4.4
PC(36:1) + K+ 826.5733 15.8 ± 0.7 19.6 ± 1.5∗ 16.3 ± 0.8 20.4 ± 0.5∗ 22.2 ± 1 26.2 ± 0.9∗ 37.7 ± 1.1 42.0 ± 3.6 28.1 ± 0.8 28.2 ± 0.9
PC(38:6) + K+ 844.5270 10.3 ± 0.7 13.5 ± 1.1∗ 8.4 ± 0.4 11.3 ± 1.0∗ 8.3 ± 0.6 10.3 ± 1.2 6.5 ± 0.5 8.5 ± 1.6 12.9 ± 1.1 16.1 ± 0.6∗
PC(38:4) + K+ 848.5572 8.1 ± 0.9 8.7 ± 1.1 12 ± 0.6 15.7 ± 0.9∗ 11.1 ± 0.6 13.2 ± 1.0 8.9 ± 0.4 11.1 ± 1.1 5.3 ± 0.2 6.4 ± 0.4∗
Data are mean ± SEM values. The p-values were calculated by the unpaired two-tailed Student’s t test ∗p < 0.05, ∗∗p < 0.01.
FIGURE 3 | MALDI-IMS images representing different lipid species that showed statistically significant differences in the detection intensities between WT and
maLPA1-null mice. The color images were obtained following the IMS conditions of 150 µm of spatial resolution, 10 shots per pixel at laser fluence of 15 µJ. The
intensity of each lipid species is represented on the color scale, shown on the right side, as a ratio of the most abundant signal.
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TABLE 4 | MALDI-IMS intensities (expressed as % of the most abundant peak) of molecular species of PC, PE, and PS in positive and negative ion detection modes that
were modified in sagittal brain sections from WT (n = 5) compared to CB1 KO mice (n = 5).
Cortex Hippocampus Striatum Cerebellum
Assignment Exp(m/z) WT CB1 KO WT CB1 KO WT CB1 KO WT CB1 KO
PC(32:0)+ 736.5654 33.2 ± 3.7 54.7 ± 6.5∗ 37.6 ± 3.6 65.4 ± 3.1∗∗ 31.4 ± 4.1 49.3 ± 6∗ 42.3 ± 7.5 51.4 ± 4
PC(34:1)+ 760.5856 51.2 ± 4.8 69.5 ± 4.5∗ 48.6 ± 5.0 67.7 ± 3.5∗ 51.7 ± 5.2 67.7 ± 5.1∗ 65.2 ± 7.9 72.3 ± 4.2
PE(p18:0/22:6)− 774.5432 3.7 ± 0.1 1 ± 0.6∗∗ 3.4 ± 0.2 1.1 ± 0.6∗ 1.4 ± 0.2 0.9 ± 0.2 4.1 ± 1.2 1.5 ± 0.5
PE(18:0/22:6)− 790.5381 12.6 ± 0.7 10 ± 2.9 8.5 ± 0.3 4.4 ± 1.9∗∗ 9.5 ± 1.2 6 ± 0.9 10.6 ± 2 5.6 ± 0.9∗
PS(18:0/22:6)− 834.5252 73.3 ± 9.5 46.9 ± 4.7∗∗ 53.9 ± 4.5 44.9 ± 4.3 57.9 ± 4.8 40 ± 2.7∗ 41.1 ± 7.7 32.6 ± 2.4
Data are mean ± SEM values. The p-values were calculated by the unpaired two-tailed Student’s t test ∗p ≤ 0.05, ∗∗p ≤ 0.01.
LPA1 receptor could lead to an adaptive regulation in CB1-
mediated activity.
On the other hand, when the activity of LPA1 receptors
was analyzed in CB1 KO mice, the LPA1 receptor activity was
increased only in the amygdala compared with WT mice. The
CB1 receptor plays an important role in processes mediated
by the amygdala, such as emotional responses (Azad et al.,
2004; Laviolette and Grace, 2006; Roche et al., 2007; Tan et al.,
2010). The eCB system in the amygdala has also been implicated
in pain modulation (Manning et al., 2003), fear conditioning
(Marsicano et al., 2002), anxiety (Imperatore et al., 2015) and
fear-conditioned learning (Llorente-Ovejero et al., 2017). The
LPA1 receptor plays a crucial role in the extinction of fear
conditioning (Pedraza et al., 2014) and has been associated with
the mixed depressive-anxiety phenotype (Moreno-Fernandez
et al., 2017). Our results suggest that the lack of the CB1 receptor
leads to an increased LPA1 receptor activity in the amygdala, as
a compensatory effect exerted by LPA signaling in this limbic
area. Considering the present results, it is difficult to hypothesize
why no other brain regions have been regulated in CB1 KO mice,
this regional exclusivity to the amygdala emphasizes the already
reported role of LPA1 receptors in fear extinction, that might be
indicating a close physiological control in anxiety behavior and
fear-conditioned learning together with CB1 receptors. However,
other functions modulated by the eCB system, such as pain
or movement control, are possibly not being compensated by
LPA1 signaling.
The lack of LPA1 receptor expression during mouse
development led to an increase in the activity of the CB1
receptor in the cortical area and cerebellum, and the lack of
the CB1 receptor led to an increase in LPA1 receptor activity
in the amygdala. Therefore, the absence of neurotransmissions
mediated by CB1 or LPA1 receptors in each strain of knockout
mice converged to a common compensatory mechanism between
both systems in some specific brain areas (cortex, cerebellum and
amygdala). The reported compensation would affect receptors
coupled to other types of G proteins, however, as previously
mentioned, we were only able to analyze those coupled to the
Gi/o subtype. It is improbable that CB1 receptors play a role since
previous results reported a similar distribution regarding the
CB1 receptor autoradiographic densities compared to functional
autoradiography stimulated by specific agonists such as the
WIN55212-2 (Llorente-Ovejero et al., 2018). However, it has not
been yet possible to get the distribution of LPA1 receptors.
Moreover, the co-regulation of eCBs and LPA must be
yielded during the pre- and postnatal development of both
strains of mice.
The mechanisms underlying the observed modulation of
CB1 receptors in LPA1-null mice may involve an increase
in the expression of CB1 receptors mediated by another
subtype of LPA receptors coupled to Gi/o proteins (see
Supplementary Material).
The metabolic precursors of the endogenous agonists for both
neurolipid systems, eCB and LPA, are PLs present at the cellular
membranes. The metabolism of PLs such as PC, PS and PE
is thought to be responsible for the synthesis of LPA and the
eCBs AEA and 2-AG. Therefore, we also hypothesized that the
identification of specific PL modifications in the brain of CB1-
and LPA1-KO mice would help us to understand the molecular
neuroscience of the interactions between both systems. Thus, the
PL precursor localization was an important step to clarify the
synthesis of these lipid mediators. The application of the MALDI-
IMS technique to maLPA1-null and CB1 KO mice allowed us
to determine the anatomical localization of each lipid species
in brain tissue slices. Unlike classical neurotransmitters, eCBs
and LPA are not stored in specific compartments of the cells,
such as vesicles, but instead are produced mainly “on demand”
by stimulus-dependent cleavage of membrane PL precursors
(Schmid et al., 1990; Di Marzo et al., 1994; Sugiura et al.,
1995; Aoki, 2004). However, little is known about which are the
specific lipid species for the synthesis of the endogenous agonists
LPA, AEA, and 2-AG, or about their anatomical localization
within the brain.
The results obtained with the MALDI-IMS assay in maLPA1-
null and WT mice showed differences in the intensity of some
lipid species, mainly in the positive ion detection mode. The
affected species were PA(16:0/18:1) + K+ and four different
PCs, including PC(32:0), PC(36:1) + K+, PC(38:6) + K+, and
PC(38:4) + K+, whose more probable acyl chains were assigned
based on previous studies and were identified as 16:0, 18:0, 18:1,
20:4, and 22:6 (Sugiura et al., 2009; Berry et al., 2011; Martinez-
Gardeazabal et al., 2017). Although much has been learned about
the physiological roles of LPA through the analyses of LPA
receptors, the mechanism by which LPA is produced remains
unclear. At least two pathways have been postulated. In the first
pathway, LPA would be produced from PL by the autotaxin
enzyme. In the second pathway, PA would be generated from PL
or diacylglycerol and then deacylated by different phospholipases,
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FIGURE 4 | MALDI-IMS images representing the different lipid species that
showed statistically significant differences in the detection intensities between
WT and CB1 KO mice. The spectra were recorded with 150 µm spacing. Ten
shots at each point were accumulated. Laser fluency was set at 15 µJ.
such as PLA1 or PLA2 (Aoki, 2004; Aoki et al., 2008). The
predominant fatty acyl moieties identified for LPA in rat brain are
18:1 (46.9%), 18:0 (22.5%), and 16:0 (18.8%), although a relatively
small, but significant, amount of a 20:4-containing species has
also been detected (7.2%) (Das and Hajra, 1989; Sugiura et al.,
1999). PC species with arachidonic acid as its acyl chain PC(38:4),
which was significantly increased in maLPA1-null mice in the
cerebellum, could be a precursor of LPA (20:4). This species could
be converted to 2-AG through LPA-phosphatase and trigger the
increase in CB1 receptor activity (Nakane et al., 2002). Moreover,
PC(36:1) is significantly increased in most of the analyzed areas
and tended to increase in the maLPA1-null mice in brain areas
where LPA1 receptors are specifically distributed, suggesting that
PC(36:1) is a potential precursor for LPA synthesis (Gonzalez de
San Roman et al., 2015; Mihara et al., 2019).
Regarding the MALDI-IMS results in CB1 KO and
corresponding WT mice, the ratio of some lipid species
was changed compared to WT mice, in both positive and
negative ion detection modes. The affected species were PCs, PEs
and PSs. PC(32:0) and PC(34:1) were increased approximately
50% in CB1 KO mice in some areas, such as the hippocampus
and frontal cortex. We assumed that changes in PC(32:0) and
PC(34:1) indicated that the lack of the CB1 receptor led to an
increase in the abundance of lipids with palmitic acid. Both
PCs can contain palmitic acid at fatty acyl moieties, and the
CB1 receptor is palmitoylated for efficient coupling to a specific
subset of G proteins located on membrane lipid rafts with a high
concentration of saturated fatty acids (Oddi et al., 2012).
The synthesis of AEA and 2-AG could be produced
by the cleavage or hydrolysis of membrane PL precursors.
For the synthesis of 2-AG, at least three pathways have
been proposed (Higgs and Glomset, 1994; Nakane et al.,
2002; Kano et al., 2009). The synthesis of AEA seems to
involve the enzymatic hydrolysis of the corresponding N-acyl-
phosphatidylethanolamines (NAPE) (reviewed in Schmid et al.,
1990, 1996; Hansen et al., 1998). In view of our results, we infer
that the observed decrease in PE species in CB1 KO compared
with WT mice could be related to precursors of AEA, due to the
requirement of PE molecules for AEA synthesis. This decrease
may be a modulation of PEs due to the lack of the target, the CB1
receptor. In addition, the decrease in PS species could be derived
from the PE diminution because PE is one of the sources for
PS synthesis (Vance and Tasseva, 2013). However, no changes in
AEA or 2-AG levels have been reported between CB1 KO and WT
mice (Maccarrone et al., 2001). The undergoing neuro-adaptive
metabolic changes could lead to an increase in the activity of the
enzymes responsible for the production of AEA from PE in KO
mice, but obtaining the same levels of AEA than in WT.
Globally, the absence of LPA1 or CB1 receptors is able
to induce modulation on the other system at the levels of
both signaling and synthesis of endogenous neurotransmitters,
suggesting adaptive responses between both systems during
prenatal and/or postnatal development. Future goals would be
to further clarify the relationship between the cannabinoid and
lysophosphatidic systems as neurolipid systems with potential
neuroprotective actions to identify new therapeutic treatments
that could be developed for neurodegenerative diseases, such as
Alzheimer’s disease.
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